Highnoon Laboratories Limited (HINOON)

PHARMACEUTICALSALLSHRKMIALLSHRKSE100KSE100PR

1020.54

+1.72%

As of 10-Jul-2026

52 Week RangeCurrent: 1020.54

755.561241.00

Updated: 10-Jul-2026

1M+5.8%

3M+7.3%

1Y+3.0%

3Y+201.9%

5Y+178.7%

Core annual income statement fields

Net sales

Gross profit

Operating profit

Profit before tax

Profit after tax

Show growth %

MetricsPKR(mn)	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTMas of 01-Mar-2026
Net sales	5,071	5,971	7,503	9,048	10,698	13,001	15,816	19,424	23,195	25,789	26,055
Cost of sales	-2,693	-3,125	-4,003	-4,886	-5,576	-6,585	-7,786	-10,170	-11,266	-11,662	-11,468
Gross profit	2,378	2,846	3,500	4,162	5,121	6,416	8,030	9,254	11,930	14,127	14,586
Selling/distribution expenses	-1,279	-1,600	-2,052	-2,387	-2,645	-3,416	-3,988	-4,946	-5,808	-6,312	-6,278
Administrative expenses	-245	-270	-324	-370	-448	-531	-615	-713	-796	-1,029	-1,034
Operating profit	854	976	1,124	1,405	2,028	2,468	3,427	3,595	5,326	6,786	7,275
Depreciation & amortisation	97	95	103	118	131	170	190	246	310	373	375
EBITDA	951	1,071	1,227	1,523	2,158	2,639	3,617	3,841	5,636	7,159	7,650
Financial charges	-6	-5	-8	-24	-24	-36	-54	-136	-394	-122	-106
Other income	19	29	33	85	104	163	305	170	423	447	453
Other charges	-77	-88	-92	-125	-186	-223	-332	-327	-515	-527	-569
Profit before tax	790	912	1,056	1,341	1,922	2,372	3,346	3,302	4,839	6,584	7,052
Taxation	-255	-286	-330	-370	-501	-564	-928	-899	-1,586	-2,465	-2,893
Profit after tax	535	626	726	971	1,421	1,808	2,417	2,403	3,254	4,119	4,160
EPS - Basic	9.02	10.55	12.45	16.66	24.37	31.02	41.47	45.35	61.41	77.75	78.52
EPS - Diluted	9.02	10.55	12.45	16.66	24.37	31.02	41.47	45.35	61.41	77.75	78.52
DPS	3.66	4.82	7.02	7.72	9.80	14.37	15.81	30.01	40.01	50.00	-